Current Conditions

Partly Cloudy
15.7°C

Man dies after taking part in French drug trial

French Health Minister Marisol Touraine, left, and Professor Gilles Edan, the chief neuroscientist at Rennes Hospital, address the media during a press conference held in Rennes, western France, Friday, Jan. 15, 2016. Six previously healthy medical volunteers have been hospitalized — including one man who is now brain dead — after taking part in a botched drug test at the Biotrial lab in western France, the French Health Ministry said Friday.
Image Credit: AP Photo/David Vincent
January 17, 2016 - 9:34 AM

PARIS - A man died in a French hospital Sunday after taking part in a drug trial for a painkiller based on a compound similar to cannabis, and five other participants remain hospitalized.

The Rennes University Hospital announced the death in a statement, but didn't identify the patient, who had already been in a state of brain death.

He was among six male volunteers between 28 and 49 hospitalized last week after volunteering to take the experimental drug. French health authorities have said three of the hospitalized volunteers face possible brain damage, and an investigation is underway into what French Health Minister Marisol Touraine called "an accident of exceptional gravity."

The trial, which began Jan. 7, involved 90 healthy volunteers who were given the experimental drug in varying doses at different times.

The hospital said it has contacted the 84 other volunteers exposed to the new painkiller. Ten of those volunteers underwent medical exams Saturday but the hospital found no anomalies, the statement says. It said another five will have medical exams closer to their homes.

The drug, based on a natural brain compound similar to the active ingredient in marijuana, was given orally to healthy volunteers as part of a Phase 1 trial by Biotrial, a drug evaluation company based in Rennes, on behalf of the Portuguese pharmaceutical company Bial.

In addition to treating pain, the drug was intended to ease mood and anxiety troubles as well as motor problems linked to neurodegenerative illnesses by acting on the endocannabinoid system. In this system, natural brain compounds act on specific receptors to exert their effects.

It's rare for volunteers to fall seriously ill during Phase 1 trials, which study safe usage, side effects and other measures on healthy volunteers, rather than drug effectiveness.

News from © The Associated Press, 2016
The Associated Press

  • Popular kamloops News
  • Comments
  • Murder victim found in Kelowna orchard identified
    KELOWNA - The identity of the woman whose body was found in a Kelowna orchard last week has been made public on social media. Kelowna resident Russia Katalina Nicholson was just 23-years-old
  • Nasty weather forecast for Thompson, Shuswap tomorrow
    THOMPSON-SHUSWAP - The Thompson and Shuswap could be in for some blustery weather tomorrow by midday. Environment Canada has issued a special weather statement warning of strong wind gusts a
  • Westsyde residents face uphill battle to bring Timmies to neighbourhood
    KAMLOOPS - It took just six days for 1,242 Westsyde residents to sign a petition calling for Tim Hortons to consider allowing a franchisee to open up shop at the corner of Westsyde Road and Overla
  • UPDATE: Missing Kamloops teen located
    UPDATE: 5:06 a.m. Monday, Oct. 16, 2017 KAMLOOPS - RCMP say a missing 18-year-old girl has been located. All personal information about the missing person has been removed from this
  • Vernon home 'known to police' shot up Sunday morning
    VERNON - Police say a burned out vehicle is related to a nearby incident where shots were fired at a Vernon home that is 'known to police' early Sunday morning.  Vernon RCMP sai
View Site in: Desktop | Mobile